ARTHRITIS R&D and SOFREMIP are very pleased to announce that "Application for fellowship ARTHRITIS R&D-SOFREMIP 2021" is open:
ARTHRITIS is funded by donors concerned by Rheumatic and Musculoskeletal Diseases (RMDs) and supported by Clarins. The Fondation’s goal is to discover new treatment and diagnostic solutions against RMDs. The Fondation amplifies and accelerates scientific innovation in the area of joint disease (genomics, proteomics, biomarkers, immunology, biotherapies,...). For 30 years, the Fondation funded 11M€ of research on 550 scientific projects, generating 350 publications. The Fondation originally supported the discovery of a diagnostic test of rheumatoid arthritis, now used worldwide as an official diagnostic criteria.
ARTHRITIS R&D, company founded in 2014 as a full-subsidiary of Fondation ARTHRITIS, develops research programs on RMDs in collaboration with academic laboratories, with a potential of application on the market through pharmaceutical partnerships.
For 2021, ARTHRITIS R&D and SOFREMIP (Société Francophone pour la Rhumatologie Et les Maladies Inflammatoires en Pédiatrie) will finance a fellowship grant.
For any further information about this Call for Proposals, please contact Yosra Messai:
firstname.lastname@example.org / Tel: +33 (0)1 56 60 68 37